SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-16-104976
Filing Date
2016-03-03
Accepted
2016-03-03 10:16:49
Documents
1
Period of Report
2015-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 5061
  Complete submission text file 0001209191-16-104976.txt   6977
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVENIDA DIAGONAL 549, 5TH FLOOR BARCELONA U3 E-08029
Business Address AVENIDA DIAGONAL 549, 5TH FLOOR BARCELONA U3 E-08029 34-93-600-3716
Grupo Ferrer Internacional, S.A. (Reporting) CIK: 0001623398 (see all company filings)

State of Incorp.: U3 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-51820 | Film No.: 161479825

Mailing Address AVENIDA DIAGONAL 549 5TH FLOOR BARCELONA U3 E-08029
Business Address
Ferrer-Salat Sergio (Reporting) CIK: 0001668295 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51820 | Film No.: 161479824